Whole-body PET/CT screens Li-Fraumeni patients for range of cancers

April 22, 2008 Whole-body PET/CT screens Li-Fraumeni patients for range of cancers Don Rauf -------------------------------------------------------------------------------- Though whole-body PET/CT is expensive, it may prove its worth by periodically screening Li-Fraumeni syndrome patients for the emergence of various cancers that are characteristic of the rare and dangerous genetic disorder. LFS patients are extremely susceptible to a range of cancers that can appear anywhere in the body, frequently when the patient is young. Preliminary research from the Dana-Farber Cancer Institute in Boston showed that whole-body fluorine-18 FDG-PET/CT scanning identified unsuspected but treatable tumors in three of 15 patients studied.

See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC